Clinical Services

Quick Links:

Inpatient Clinical Services:

 
 

Outpatient Clinical Services:

End Stage Lung Disease/Pulmonary Fibrosis

Lisa Lancaster, M.D. 

Lung Transplant Clinic

Ivan Robbins, M.D.
Mark P. Steele, M.D.

Vanderbilt Adult Cystic Fibrosis Clinic

Bonnie Slovis, M.D.
Alison Miller, M.D.
James Tolle, M.D.
Elisabeth Willers, M.D

Vanderbilt Asthma, Sinus and Allergy Program (A.S.A.P.) Center

John Fahrenholz, M.D.
Peggy Kendall, M.D.
Ryszard Dworski, M.D.
S. Bobo Tanner, M.D.
Kenneth Babe, M.D
Robert Valet, M.D.

Vanderbilt General Pulmonary Clinics

Brenda Butka, M.D.
Brian Christman, M.D.
Tina Hartert, M.D.
Lisa Lancaster, M.D.
Robert Miller, M.D.
Otis Rickman, D.O.
Bonnie Slovis, M.D., M.S.H.S.
James Tolle, M.D.
Elisabeth Willers, M.D.
Carla Sevin, M.D.

Vanderbilt Pulmonary Function Lab

James Sheller, M.D.
James Tolle, M.D.

 

Vanderbilt Pulmonary Hypertension Center

Ivan Robbins, M.D.
Anna Hemnes, M.D.

Vanderbilt Sleep Disorders Clinic

James Sheller, M.D. 
Lisa Lancaster, M.D. 
Paula Watson, M.D. 

Vanderbilt Thoracic Oncology Clinic

Pierre Massion, M.D.
Alison Miller, M.D.
Robert Miller, M.D.
Otis Rickman, D.O.
Bonnie Slovis, M.D., M.S.H.S.
James Tolle, M.D.
Elisabeth Willers, M.D.


Inpatient Clinical Services

Vanderbilt Pulmonary Service

A board certified Pulmonologist, Pulmonary Critical Care Fellow, and medical sub-specialty resident comprise the Vanderbilt inpatient pulmonary service. Attending faculty/physicians staff the inpatient consult service on a monthly basis. Directed by Timothy Blackwell, M.D., the pulmonary consult service provides 24-hour a day consultation for pulmonary and critical care problems for patients outside the medical intensive care unit. This service also accepts patients with pulmonary problems in transfer for hospital admission.

The team makes daily rounds, and performs all necessary procedures including bronchoscopy, thoracentesis, pleural biopsy, diagnostic and therapeutic vascular catheterization, and chest tube insertion. The team is also responsible for interpretation of pulmonary function tests. In addition to providing state of the art patient care, a key role of the consults service attending is to provide education of fellows, house officers, and medical students.

To request a consultation or to inquire about the transfer of a non-critically ill patient to the pulmonary service, contact the pulmonary consult fellow through the Vanderbilt Operator at (615) 322-5000 or the Division Clinic at (615) 322-2386.

 

Vanderbilt Critical Care Service

Twenty-four hour a day critical care services are provided in the Vanderbilt Medical ICU. This unit, under the Direction of Art Wheeler, M.D. is a new 34 bed state of the art facility caring for critically ill adults. Continuous physician coverage is provided by three teams of medical residents supervised by two second or third year pulmonary-critical care fellows and two dedicated faculty members. Faculty staff the units on two week rotations. House officers and Critical Care Fellows staff the unit on monthly rotations. Patient transfers from other hospitals can be accomplished by ground ambulance or via the LifeFlight air transport service.

A limited number of faculty attend in the MICU and all have been board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine. This team provides initial evaluation and ongoing care of the critically ill patient and is responsible for performance of all procedures including, diagnostic and therapeutic vascular catheterization, intubation, chest tube insertion, thoracentesis, and bronchoscopy. Because the unit stresses high quality, cost effective patient care delivered in a collaborative environment, it has become a national leader in critical care education and research. Nurses, respiratory therapists, pharmacists, nutritionists, and physical therapists actively participate in daily bedside teaching and work rounds.

Consensus "critical pathways" for the most common admission problems are used extensively to improve care and control costs. Six diagnoses account for most ICU admissions: severe sepsis, acute respiratory distress syndrome, gastrointestinal bleeding, lung transplantation, and poisoning or overdose. The MICU has an active program of research projects to discover new therapies and improve patient care. Currently projects in enteral nutrition, ARDS treatment, delirium, sleep disorders and pain control in the critically ill are ongoing.

To obtain a critical care consult or to transfer a patient to the MICU at any time, contact the Transfer Center at (615) 343-0976. Non-emergent consults should be referred to the Pulmonary Consult Fellow.

 

Outpatient Clinical Services

End Stage Lung Disease/Pulmonary Fibrosis

Dr. Jim Loyd and Dr. Lisa Lancaster direct the End Stage Lung Disease/Pulmonary Fibrosis Clinic. This clinic aims to provide patients with comprehensive evaluation and management recommendations that include the latest therapies available. Patients may also be evaluated and screened for future lung transplantation.

 

Lung Transplant Clinic

The Lung Transplant Program is directed by Drs. Mark Steele, Ivan Robbins, Lisa Lancaster and James Loyd. In addition, two nurse practitioners provide able assistance. The clinics are divided into a pre-transplant evaluation clinic (Tuesday and Thursday) and a post-transplant follow up clinic (Tuesday mornings). Over 180 patients have been transplanted at Vanderbilt and the clinics provide life-long care for all lung transplant recipients. Patients and physicians may reach the staff of the Lung Transplant Program 24 hours a day (615) 936-0393.

The Vanderbilt Lung Transplant Program began in 1987 under the direction of Dr. William Frist. The survival following lung transplant at Vanderbilt is similar to the national survival rates tracked by the United Network for Organ Sharing (UNOS). Dr. Eric Lambright, the surgical director of the program, and Dr. Eric Grogan performs the majority of the surgeries in conjunction with the Vanderbilt Thoracic Surgery Department.

Lung transplantation may be appropriate for patients with end stage emphysema, cystic fibrosis, pulmonary hypertension or pulmonary fibrosis and EARLY referral is recommended to provide adequate time for a comprehensive evaluation and counseling for patients/ families. Lung transplantation is generally reserved for patients less than age 65 who do not have other significant medical condition. A brochure for patients and physicians, which explains lung transplantation, its limitations and the details of the Vanderbilt program, can be requested by phone at (615) 936-0393 or at http://www.vanderbilthealth.com/transplant/10793. Consultation for referring physicians is available 24 hours a day with the medical co-director, Ivan Robbins.

 

Vanderbilt Adult Cystic Fibrosis Clinic

Most patents with cystic fibrosis now live into adulthood and collectively represent an important and rapidly growing patient group for adult pulmonary-critical care physicians. The Division's Cystic Fibrosis Foundation Accredited Adult Cystic Fibrosis Program is directed by Bonnie Slovis, M.D., M.S.H.S, who together with Elisabeth Willers, M.D., the Associate Program Director, and Alison Miller, M.D.,  provide expert and comprehensive care to approximately 180 adults with Cystic Fibrosis.  Not only does the Adult Cystic Fibrosis Program provide state of the art clinical care, it also serves as a venue for Resident and Fellow education. Patients are provided the opportunity to participate in investigational studies of new drug and gene therapies available on a limited basis. Faculty and staff of the Adult Cystic Fibrosis Clinic can be contacted at (615) 322-2386.

 

The Vanderbilt Asthma, Sinus and Allergy Program (A.S.A.P.) Center

The Asthma, Sinus and Allergy Program (A.S.A.P.), located at 2611 West End Avenue, is a multi-disciplinary clinic in which pulmonologists, allergists, and ear nose and throat specialists work together to provide timely outpatient consultation, evaluation and management of patients with asthma, sinus and allergic rhinitis problems. A.S.A.P. offers comprehensive on-site diagnostic evaluations including CT scanning, pulmonary function and allergy testing. An important component of the program for patients is the Centers extensive patient education and outcome monitoring programs.

Routine and urgent appointments are welcome and the Center offers acute care as well as long term disease management. Convenient facilities and hours are available for allergy desensitization patients. Additionally, the Center offers patients the opportunity to receive investigational therapies for asthma, and allergic diseases as part of research study protocols. The A.S.A.P. Center physicians can be reached at (615) 936-2727.

 

Vanderbilt General Pulmonary Clinics

Faculty members of the Division conduct general outpatient referral pulmonary clinics, located in the Vanderbilt Clinic building. The pulmonary outpatient clinic practice, directed by Bonnie Slovis, M.D., M.S.H.S., with the expert assistance of clinic manager Matt Pearson, MHA, MBA and assistant manager Kim Frazier, R.N., provides a full range of pulmonary consultative services and diagnostic and therapeutic procedures. Both first time consultation and ongoing care are provided in this clinical setting. In addition to efficiently delivering state of the art patient care, the clinical outpatient practice serves as a training venue for Pulmonary Critical Care Fellows who are paired with a faculty member for the duration of their Fellowship.

Common problems seen include the evaluation of dyspnea, diagnosis and therapy of asthma and chronic obstructive pulmonary disease, evaluation and therapy of pleural and interstitial lung disease and the evaluation of abnormal chest radiographs. In addition specific faculty have interest in lung manifestations of rheumatologic disease, sarcoidosis, emphysema, immune deficiency syndromes, infectious diseases of the lung, occupational lung disease, and mediastinal fibrosis. To make an appointment, or for questions call (615) 322-2386.

Specialized clinics exist for the evaluation and care of patients requiring lung transplantation, and those with pulmonary hypertension, lung cancer, adult cystic fibrosis, neuromuscular weakness, and allergic disorders and are described in separate sections.

Bronchoscopy, transthoracic needle biopsy, thoracentesis, transtracheal oxygen catheter placement and exercise physiology studies are all regularly performed on an outpatient basis.

 

Vanderbilt Pulmonary Function Lab

The Vanderbilt Pulmonary Function Laboratory, directed by James Tolle, M.D. offers a full range of pulmonary function testing including spirometry, lung volume measurements, diffusing capacity determinations, body box plethysmography, arterial blood gas analysis, and cardiopulmonary exercise and methacholine broncho-provocation testing.

The laboratory, located in the basement of Vanderbilt Clinic Building, uses state of the art equipment and highly trained staff to deliver timely and accurate results. Same day testing and interpretation of routine pulmonary function studies rarely can't be accomplished. The lab staff and Pulmonary Division faculty are happy to answer questions about pulmonary function test results or assist physicians in the selection of appropriate tests. Because of manpower requirements, exercise and broncho provocation tests typically require advance scheduling. The direct phone number for the Pulmonary Function Lab is (615) 322-0626. Scheduling for the Pulmonary Function Lab can be achieved by calling (615) 322-4752.

 

Vanderbilt Pulmonary Hypertension Center

To refer a patient for an appointment in our Pulmonary Hypertension Clinic or to speak with a nurse coordinator regarding these studies please contact: Tracy Oyler, at 322-4605
.

Vanderbilt Pulmonary Sleep Disorders Clinic

The Vanderbilt Sleep Disorders Pulmonary Clinic is staffed by James Sheller, M.D., Paula Watson, M.D., and Lisa Lancaster, M.D., each board certified in Pulmonary and Sleep Medicine. The clinic is located in the Vanderbilt Clinic Building in the B-800 area. The Sleep Disorder Clinic provides comprehensive diagnostic services for patients with a variety of sleep problems including sleep apnea syndromes, narcolepsy, insomnia, and movement disorders. Clinical evaluation, sleep studies (polysomnography) and therapy are available. The staff of the Sleep Disorders Center can be contacted at (615) 322-4000. The two fully credentialed laboratories are located at the West End Marriott Hotel in Nashville and the Franklin center at the Hyatt Hotel on Bakers Bridge Road. The Vanderbilt Sleep Center is under the direction of Raghu Upender, M.D.
Website: Website: http://www.mc.vanderbilt.edu/neurology/sleep.htm

 

Vanderbilt Thoracic Oncology Program

Thoracic Oncology Clinic is a multi-disciplinary outpatient program, staffed by faculty pulmonologists led by Bonnie Slovis, M.D., M.S.H.S. as well as, medical oncologists, radiation oncologists, thoracic surgeons, oncology and pulmonary fellows. The program is designed to expeditiously evaluate lung masses and begin appropriate therapy. In addition to efficiently serving patients, the program serves as a valuable teaching site for trainees. Patients with thoracic malignancies are offered the opportunity to participate in cutting edge clinical research trials. The Vanderbilt Ingram Cancer Center is designated as one of only 40 Comprehensive Cancer Centers by the National Institutes of Health. Patients or physicians seeking more information can contact 615-343-8550.

 

Vanderbilt Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Center

The Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Center originated in 1998 with the enrollment of the first patient in the Avonex placebo-controlled trial for the treatment of Idiopathic Pulmonary Fibrosis (IPF). Since that time the IPF/ILD Center has grown to become a nationally respected IPF center for healthcare, patient education/support group, IPF clinical trials, and lung transplantation.
Since the initiation of our IPF/ILD center, ninteen national and international IPF clinical trials have been available for our patients. Essentially all the phase 2/3 studies in the US that have been conducted for IPF patients have been conducted at Vanderbilt as well. This is an enormous resource for patients in our state and surrounding states. We have been the top enroller or one of the top five enrollers in all IPF clinical trials placebo-controlled trials to date. Most recently, we have become a member of an elite group of 11 nationally recognized IPF centers as part of the National Institutes of Health IPF network.
The IPF/ILD Center, created initially by Dr. James Loyd, is directed by Dr. Lisa Lancaster. Additionally, our center staffs a nurse practitioner, a research nurse, and a study coordinator. Working together, they provide a unique center that evaluates patients not only for the latest healthcare options, but also for clinical trials and for lung transplantation. We are one of only 3 IPF centers in the IPF network who can evaluate patients for all treatment options including transplant at their first clinic visit. Our center hosts a monthly IPF support group founded to provide support and education to IPF patients and their families. Because of our coordinated care and ability to evaluate patients for multiple options in the setting of a disease that in the community has few if any options, we have developed an expansive referral base. Our patients come not only from Tennessee but also from Arkansas, Missouri, Illinois, Indiana, North Carolina, Alabama, Kentucky, Mississippi and Georgia.

 

Vanderbilt Pulmonary Diagnostic and Interventional Program

Vanderbilt has 2 new state of the art bronchoscopy and interventional procedure suites, directed by Otis Rickman, D.O.
Diagnostic and interventional bronchoscopy using the latest tools enable the rapid diagnosis and treatment of pulmonary, pleural, and airway diseases.  New technologies include endobronchial ultrasound for fine needle aspiration, superdimension guided biopsy of peripheral lesions, lasers and stents for management of airway disease, endobronchial brachytherapy, and autoflorescence bronchoscopy to detect dysplastic and insitu carcinomas.